At BlackDoctor.org, we are committed to promoting equitable healthcare access for underserved communities. Dr. Farhan Bhatti’s compelling op-ed in The Detroit News on November 12th, highlights the urgent need to address unaffordable prescription drug prices. We strongly support his call for reform, while also emphasizing the need for transparency in the 340B Program and across the pharmaceutical supply chain.
The 340B Program, created to assist hospitals and clinics serving low-income patients by providing discounted medications, has helped many in need. However, its lack of transparency has raised concerns that some participating entities may not reinvest these savings into patient care. Reforming the program to ensure its benefits are directly passed on to underserved patients is essential to uphold its original mission. Addressing systemic inequities requires ensuring existing programs work as intended.
Michigan legislators are quickly pushing SB 1179, which, while well-intentioned, oversimplifies the complex issues surrounding the 340B Program, potentially compounding existing inefficiencies.
Our communities deserve a healthcare system that prioritizes patients. By championing reforms to the 340B Program, Michigan can lead the way in building a fair and equitable system that works for all.
At BlackDoctor.org, we stand with Dr. Bhatti in urging Michigan lawmakers to seek these necessary reforms. However, SB 1179 misses the opportunity to address systemic issues within the 340B program and risks perpetuating inefficiencies that fail to serve Michigan’s most vulnerable residents effectively. A more balanced approach is necessary to uphold the program’s original mission while fostering accountability. The legislation should not be rushed through at the final hour.
By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.
